What is Santen Pharmaceutical Co., Ltd.’s 1-month forecast?

Meyka AI projects SNPHY could trade near $10.09 in the next month, a move of -1.56% compared to today’s price.

What is Santen Pharmaceutical Co., Ltd.’s 1-year forecast?

By 2027, SNPHY is forecasted to reach $10.65, reflecting a 3.86% change from the current level.

What is Santen Pharmaceutical Co., Ltd.’s 5-year forecast?

The 2030 projection for SNPHY is $10.39, which represents a potential 1.38% change.

What is the 7-year outlook for Santen Pharmaceutical Co., Ltd.?

Over the next 7 years, SNPHY could trade around $9.95, showing a -2.97% move from today’s price.

Can Santen Pharmaceutical Co., Ltd. (SNPHY) reach $15.6 by 2030?

Meyka AI’s 2030 forecast places SNPHY at $10.39, making it unlikely to reach $15.6 by 2030 under current market conditions.

Santen Pharmaceutical Co., Ltd.

SNPHY•PNK

Healthcare

Drug Manufacturers - General

$10.25

$-0.12(-1.16%)

U.S. Market opens in NaNh NaNm

Santen Pharmaceutical Co., Ltd. (SNPHY) Stock Forecast & Price Predictions

Get the latest Santen Pharmaceutical Co., Ltd. (SNPHY) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$10.09

Change↓ $-0.16 (-1.56%)

Quarterly Forecast

Predicted Price$13.59

Change↑ $3.34 (32.59%)

Yearly Forecast

Predicted Price$10.65

Change↑ $0.40 (3.86%)

3 Years Forecast

Predicted Price$10.53

Change↑ $0.28 (2.69%)

5 Years Forecast

Predicted Price$10.39

Change↑ $0.14 (1.38%)

7 Years Forecast

Predicted Price$9.95

Change↓ $-0.30 (-2.97%)

Santen Pharmaceutical Co., Ltd. Stock Forecast Summary

Santen Pharmaceutical Co., Ltd. (SNPHY) stock is currently priced at $10.25. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $10.09.

In the long term, SNPHY shows a bullish trend. The 2027 forecast points to $10.65 (3.86% change), while the 2031 forecast suggests $10.39 (1.38% change). Looking 7 years ahead, projections estimate the stock could trade near $9.95, a -2.97% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bearish

Long-Term Outlook

Bullish

This mix indicates that Santen Pharmaceutical Co., Ltd. stock is expected to trade sideways over the coming years.

Investment Calculator

Estimate your potential returns on SNPHY using our advanced Investment Calculator with AI-driven price forecasts. Enter your investment amount and select a target date to view expected results, including estimated profit, loss, and ROI performance.

Based on your investment of ¥1,000.00 in Santen Pharmaceutical Co., Ltd. and holding until April 28th, 2027, you could face a potential +¥38.63 profit, reflecting a +3.9% ROI over the next 365 days. These projections help you better understand short-term market movements.

Investment Amount (USD)

HODL Until?

$Shares Bought

97.5610

@ ¥10.25/share

~Forecast Price

¥10.65

1-year AI forecast

$Est. Portfolio Value

¥1,038.63

+¥38.63 profit

%ROI

+3.9%

return on investment

Santen Pharmaceutical Co., Ltd. yearly Price Forecast Chart

Explore the yearly forecast chart for SNPHY, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Santen Pharmaceutical Co., Ltd. over different timeframes.

No forecast data available

No prediction data found for this time period.

Forecasting data is not available for SNPHYForecasting details for SNPHY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Santen Pharmaceutical Co., Ltd. Stock Forecast 2026

The forecast for Santen Pharmaceutical Co., Ltd. (SNPHY) in 2026 suggests a price of $10.65, representing a 3.86% move from today’s price.

Average Target: $10.65

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:

Earnings growth projections.
Competitive performance in the Healthcare.
Macroeconomic factors such as interest rates and inflation.

Santen Pharmaceutical Co., Ltd. Stock Forecast 2030

By 2030, Meyka AI projects SNPHY could trade near $10.39, showing a potential 1.38% compared to current levels.

Average Target: $10.39

Market Outlook: bullish.

What could influence the 2030 forecast:

Technological innovation and product cycles.
Expansion into global markets.
Long-term investor sentiment toward Santen Pharmaceutical Co., Ltd..

Santen Pharmaceutical Co., Ltd. 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for SNPHY points to a price around $9.95, which is a projected -2.97% move from today’s level.

Average Target: $9.95

Outlook: bearish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:

Global economic expansion or contraction.
Regulatory and policy environment.
Santen Pharmaceutical Co., Ltd.’s ability to maintain market leadership.